Published September 25, 2006 | Version Cover Image + Published
Journal Article Open

A unified synthetic approach to the pyrazinone dragmacidins

Abstract

This review describes recent developments from our laboratory involving the synthesis of the structurally complex, pyrazinone-containing dragmacidin alkaloids.

Additional Information

© Royal Society of Chemistry 2006. Received (in Cambridge, UK) 26th April 2006, Accepted 15th June 2006. First published on the web 18th July 2006. Feature article Richmond Sarpong and Daniel Caspi are gratefully acknowledged for their outstanding contributions to the dragmacidin project. The authors thank the NIH-NIGMS (R01 GM65961-01), the NDSEG (predoctoral fellowship to N.K.G.), AstraZeneca, Boehringer Ingelheim, Johnson & Johnson, Pfizer, Merck, Amgen, Research Corporation, Roche and GlaxoSmithKline for generous funding.

Attached Files

Published - GARcc06.pdf

Cover Image - GARcc06fig1.gif

Files

GARcc06.pdf

Files (565.2 kB)

Name Size Download all
md5:692419034f785c33f97e83950657de82
532.0 kB Preview Download
md5:8cf2b9b4827b47bb236549edb84a4703
14.1 kB Preview Download
md5:3088798fdf15fc2e4d2913dfee2d6c33
15.9 kB Preview Download
md5:bc1dcf8233246319a19830a01c7f16a3
3.1 kB Preview Download

Additional details

Identifiers

Eprint ID
4941
Resolver ID
CaltechAUTHORS:GARcc06

Funding

NIH
R01GM65961-01
National Defense Science and Engineering Graduate (NDSEG) Fellowship
AstraZeneca
Boehringer-Ingelheim
Johnson and Johnson
Pfizer
Merck
Amgen
Research Corporation
Roche
GlaxoSmithKline

Dates

Created
2006-09-14
Created from EPrint's datestamp field
Updated
2021-11-08
Created from EPrint's last_modified field